메뉴 건너뛰기




Volumn 16, Issue 11, 2012, Pages

Immunogenicity and protective efficacy of heterologous prime-boost regimens with mycobacterial vaccines and recombinant adenovirus- and poxvirus-vectored vaccines against murine tuberculosis

Author keywords

Adenovirus; Boost vaccine; MVA (modified vaccinia virus Ankara); Tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; RECOMBINANT VACCINE; VIRUS VACCINE; VIRUS VECTOR;

EID: 84868208032     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.07.008     Document Type: Article
Times cited : (16)

References (72)
  • 1
    • 0003635217 scopus 로고    scopus 로고
    • World Health Organization, WHO, Geneva
    • Global tuberculosis control 2011 2011, World Health Organization, WHO, Geneva.
    • (2011) Global tuberculosis control 2011
  • 2
    • 79251572945 scopus 로고    scopus 로고
    • Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
    • Tseng C.L., Oxlade O., Menzies D., Aspler A., Schwartzman K. Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study. BMC Public Health 2011, 11:55.
    • (2011) BMC Public Health , vol.11 , pp. 55
    • Tseng, C.L.1    Oxlade, O.2    Menzies, D.3    Aspler, A.4    Schwartzman, K.5
  • 3
    • 0034455173 scopus 로고    scopus 로고
    • Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature
    • Brewer T.F. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 2000, 31(Suppl 3):S64-S67.
    • (2000) Clin Infect Dis , vol.31 , Issue.SUPPL. 3
    • Brewer, T.F.1
  • 4
    • 0032040444 scopus 로고    scopus 로고
    • Bacillus Calmette-Guerin revaccination questionable with low tuberculosis incidence
    • Tala-Heikkila M.M., Tuominen J.E., Tala E.O. Bacillus Calmette-Guerin revaccination questionable with low tuberculosis incidence. Am J Respir Crit Care Med 1998, 157:1324-1327.
    • (1998) Am J Respir Crit Care Med , vol.157 , pp. 1324-1327
    • Tala-Heikkila, M.M.1    Tuominen, J.E.2    Tala, E.O.3
  • 5
    • 0242318262 scopus 로고    scopus 로고
    • Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination
    • Buddle B.M., Wedlock D.N., Parlane N.A., Corner L.A., De Lisle G.W., Skinner M.A. Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination. Infect Immun 2003, 71:6411-6419.
    • (2003) Infect Immun , vol.71 , pp. 6411-6419
    • Buddle, B.M.1    Wedlock, D.N.2    Parlane, N.A.3    Corner, L.A.4    De Lisle, G.W.5    Skinner, M.A.6
  • 6
    • 29044431543 scopus 로고    scopus 로고
    • Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations
    • Basaraba R.J., Izzo A.A., Brandt L., Orme I.M. Decreased survival of guinea pigs infected with Mycobacterium tuberculosis after multiple BCG vaccinations. Vaccine 2006, 24:280-286.
    • (2006) Vaccine , vol.24 , pp. 280-286
    • Basaraba, R.J.1    Izzo, A.A.2    Brandt, L.3    Orme, I.M.4
  • 7
    • 0034176364 scopus 로고    scopus 로고
    • The prime-boost strategy: exciting prospects for improved vaccination
    • Ramshaw I.A., Ramsay A.J. The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today 2000, 21:163-165.
    • (2000) Immunol Today , vol.21 , pp. 163-165
    • Ramshaw, I.A.1    Ramsay, A.J.2
  • 8
    • 34548060398 scopus 로고    scopus 로고
    • Heterologous boost vaccines for bacillus Calmette-Guerin prime immunization against tuberculosis
    • Xing Z., Charters T.J. Heterologous boost vaccines for bacillus Calmette-Guerin prime immunization against tuberculosis. Expert Rev Vaccines 2007, 6:539-546.
    • (2007) Expert Rev Vaccines , vol.6 , pp. 539-546
    • Xing, Z.1    Charters, T.J.2
  • 9
    • 77953261950 scopus 로고    scopus 로고
    • Boosting BCG to protect against TB
    • Rouanet C., Locht C. Boosting BCG to protect against TB. Expert Rev Respir Med 2010, 4:339-348.
    • (2010) Expert Rev Respir Med , vol.4 , pp. 339-348
    • Rouanet, C.1    Locht, C.2
  • 10
    • 33845989506 scopus 로고    scopus 로고
    • The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis
    • Andersen C.S., Dietrich J., Agger E.M., Lycke N.Y., Lovgren K., Andersen P. The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis. Infect Immun 2007, 75:408-416.
    • (2007) Infect Immun , vol.75 , pp. 408-416
    • Andersen, C.S.1    Dietrich, J.2    Agger, E.M.3    Lycke, N.Y.4    Lovgren, K.5    Andersen, P.6
  • 11
    • 47149094823 scopus 로고    scopus 로고
    • The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response
    • Palma C., Iona E., Giannoni F., Pardini M., Brunori L., Fattorini L., et al. The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response. Vaccine 2008, 26:4237-4243.
    • (2008) Vaccine , vol.26 , pp. 4237-4243
    • Palma, C.1    Iona, E.2    Giannoni, F.3    Pardini, M.4    Brunori, L.5    Fattorini, L.6
  • 12
    • 79751497607 scopus 로고    scopus 로고
    • A multistage tuberculosis vaccine that confers efficient protection before and after exposure
    • Aagaard C., Hoang T., Dietrich J., Cardona P.J., Izzo A., Dolganov G., et al. A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nat Med 2011, 17:189-194.
    • (2011) Nat Med , vol.17 , pp. 189-194
    • Aagaard, C.1    Hoang, T.2    Dietrich, J.3    Cardona, P.J.4    Izzo, A.5    Dolganov, G.6
  • 14
    • 41849129820 scopus 로고    scopus 로고
    • Boosting BCG with recombinant modified vaccinia Ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials
    • Pathan A.A., Sander C.R., Fletcher H.A., Poulton I., Alder N.C., Beveridge N.E., et al. Boosting BCG with recombinant modified vaccinia Ankara expressing antigen 85A: different boosting intervals and implications for efficacy trials. PLoS ONE 2007, 2:e1052.
    • (2007) PLoS ONE , vol.2
    • Pathan, A.A.1    Sander, C.R.2    Fletcher, H.A.3    Poulton, I.4    Alder, N.C.5    Beveridge, N.E.6
  • 15
    • 33746632535 scopus 로고    scopus 로고
    • Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis
    • Santosuosso M., McCormick S., Zhang X., Zganiacz A., Xing Z. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis. Infect Immun 2006, 74:4634-4643.
    • (2006) Infect Immun , vol.74 , pp. 4634-4643
    • Santosuosso, M.1    McCormick, S.2    Zhang, X.3    Zganiacz, A.4    Xing, Z.5
  • 16
    • 0037178298 scopus 로고    scopus 로고
    • Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation
    • Wang J., Zganiacz A., Xing Z. Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation. Vaccine 2002, 20:2887-2898.
    • (2002) Vaccine , vol.20 , pp. 2887-2898
    • Wang, J.1    Zganiacz, A.2    Xing, Z.3
  • 17
    • 8144229025 scopus 로고    scopus 로고
    • A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity
    • Derrick S.C., Yang A.L., Morris S.L. A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 2004, 23:780-788.
    • (2004) Vaccine , vol.23 , pp. 780-788
    • Derrick, S.C.1    Yang, A.L.2    Morris, S.L.3
  • 18
    • 33845595414 scopus 로고    scopus 로고
    • Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis
    • Bennekov T., Dietrich J., Rosenkrands I., Stryhn A., Doherty T.M., Andersen P. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis. Eur J Immunol 2006, 36:3346-3355.
    • (2006) Eur J Immunol , vol.36 , pp. 3346-3355
    • Bennekov, T.1    Dietrich, J.2    Rosenkrands, I.3    Stryhn, A.4    Doherty, T.M.5    Andersen, P.6
  • 19
    • 0036181979 scopus 로고    scopus 로고
    • Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A
    • McShane H., Behboudi S., Goonetilleke N., Brookes R., Hill A.V. Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A. Infect Immun 2002, 70:1623-1626.
    • (2002) Infect Immun , vol.70 , pp. 1623-1626
    • McShane, H.1    Behboudi, S.2    Goonetilleke, N.3    Brookes, R.4    Hill, A.V.5
  • 20
    • 8444222278 scopus 로고    scopus 로고
    • Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis
    • Wang J., Thorson L., Stokes R.W., Santosuosso M., Huygen K., Zganiacz A., et al. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol 2004, 173:6357-6365.
    • (2004) J Immunol , vol.173 , pp. 6357-6365
    • Wang, J.1    Thorson, L.2    Stokes, R.W.3    Santosuosso, M.4    Huygen, K.5    Zganiacz, A.6
  • 21
    • 61549087491 scopus 로고    scopus 로고
    • A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice
    • Perera P.Y., Derrick S.C., Kolibab K., Momoi F., Yamamoto M., Morris S.L., et al. A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice. Vaccine 2009, 27:2121-2127.
    • (2009) Vaccine , vol.27 , pp. 2121-2127
    • Perera, P.Y.1    Derrick, S.C.2    Kolibab, K.3    Momoi, F.4    Yamamoto, M.5    Morris, S.L.6
  • 22
    • 26844521205 scopus 로고    scopus 로고
    • Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines
    • Xing Z., Santosuosso M., McCormick S., Yang T.C., Millar J., Hitt M., et al. Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines. Curr Gene Ther 2005, 5:485-492.
    • (2005) Curr Gene Ther , vol.5 , pp. 485-492
    • Xing, Z.1    Santosuosso, M.2    McCormick, S.3    Yang, T.C.4    Millar, J.5    Hitt, M.6
  • 23
    • 0034610299 scopus 로고    scopus 로고
    • Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model
    • Horwitz M.A., Harth G., Dillon B.J., Maslesa-Galic S. Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci U S A 2000, 97:13853-13858.
    • (2000) Proc Natl Acad Sci U S A , vol.97 , pp. 13853-13858
    • Horwitz, M.A.1    Harth, G.2    Dillon, B.J.3    Maslesa-Galic, S.4
  • 24
    • 22344433382 scopus 로고    scopus 로고
    • Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin
    • Grode L., Seiler P., Baumann S., Hess J., Brinkmann V., Nasser Eddine A., et al. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest 2005, 115:2472-2479.
    • (2005) J Clin Invest , vol.115 , pp. 2472-2479
    • Grode, L.1    Seiler, P.2    Baumann, S.3    Hess, J.4    Brinkmann, V.5    Nasser Eddine, A.6
  • 25
    • 67649321241 scopus 로고    scopus 로고
    • Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis
    • Sun R., Skeiky Y.A., Izzo A., Dheenadhayalan V., Imam Z., Penn E., et al. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis. Vaccine 2009, 27:4412-4423.
    • (2009) Vaccine , vol.27 , pp. 4412-4423
    • Sun, R.1    Skeiky, Y.A.2    Izzo, A.3    Dheenadhayalan, V.4    Imam, Z.5    Penn, E.6
  • 26
    • 32544446560 scopus 로고    scopus 로고
    • A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG
    • Horwitz M.A., Harth G., Dillon B.J., Maslesa-Galic S. A novel live recombinant mycobacterial vaccine against bovine tuberculosis more potent than BCG. Vaccine 2006, 24:1593-1600.
    • (2006) Vaccine , vol.24 , pp. 1593-1600
    • Horwitz, M.A.1    Harth, G.2    Dillon, B.J.3    Maslesa-Galic, S.4
  • 27
    • 0037378874 scopus 로고    scopus 로고
    • A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis
    • Horwitz M.A., Harth G. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect Immun 2003, 71:1672-1679.
    • (2003) Infect Immun , vol.71 , pp. 1672-1679
    • Horwitz, M.A.1    Harth, G.2
  • 28
    • 20444443800 scopus 로고    scopus 로고
    • Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins
    • Horwitz M.A. Recombinant BCG expressing Mycobacterium tuberculosis major extracellular proteins. Microbes Infect 2005, 7:947-954.
    • (2005) Microbes Infect , vol.7 , pp. 947-954
    • Horwitz, M.A.1
  • 29
    • 83455211197 scopus 로고    scopus 로고
    • Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis
    • You Q., Jiang C., Wu Y., Yu X., Chen Y., Zhang X., et al. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis. Scand J Immunol 2012, 75:77-84.
    • (2012) Scand J Immunol , vol.75 , pp. 77-84
    • You, Q.1    Jiang, C.2    Wu, Y.3    Yu, X.4    Chen, Y.5    Zhang, X.6
  • 30
    • 84862547992 scopus 로고    scopus 로고
    • Immune responses induced by heterologous boosting of recombinant bacillus Calmette-Guerin with Ag85B-ESAT6 fusion protein in levamisole-based adjuvant
    • You Q., Wu Y., Jiang D., Wang C., Wei W., Yu X., et al. Immune responses induced by heterologous boosting of recombinant bacillus Calmette-Guerin with Ag85B-ESAT6 fusion protein in levamisole-based adjuvant. Immunol Invest 2012, 41:412-428.
    • (2012) Immunol Invest , vol.41 , pp. 412-428
    • You, Q.1    Wu, Y.2    Jiang, D.3    Wang, C.4    Wei, W.5    Yu, X.6
  • 31
    • 34547634035 scopus 로고    scopus 로고
    • Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon
    • Radosevic K., Wieland C.W., Rodriguez A., Weverling G.J., Mintardjo R., Gillissen G., et al. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon. Infect Immun 2007, 75:4105-4115.
    • (2007) Infect Immun , vol.75 , pp. 4105-4115
    • Radosevic, K.1    Wieland, C.W.2    Rodriguez, A.3    Weverling, G.J.4    Mintardjo, R.5    Gillissen, G.6
  • 32
    • 0037222145 scopus 로고    scopus 로고
    • Mapping of murine Th1 helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis
    • D'Souza S., Rosseels V., Romano M., Tanghe A., Denis O., Jurion F., et al. Mapping of murine Th1 helper T-cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis. Infect Immun 2003, 71:483-493.
    • (2003) Infect Immun , vol.71 , pp. 483-493
    • D'Souza, S.1    Rosseels, V.2    Romano, M.3    Tanghe, A.4    Denis, O.5    Jurion, F.6
  • 33
    • 0032036493 scopus 로고    scopus 로고
    • Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+and CD8+T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection
    • Denis O., Tanghe A., Palfliet K., Jurion F., van den Berg T.P., Vanonckelen A., et al. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+and CD8+T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection. Infect Immun 1998, 66:1527-1533.
    • (1998) Infect Immun , vol.66 , pp. 1527-1533
    • Denis, O.1    Tanghe, A.2    Palfliet, K.3    Jurion, F.4    van den Berg, T.P.5    Vanonckelen, A.6
  • 34
    • 0030587887 scopus 로고    scopus 로고
    • Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis
    • Brandt L., Oettinger T., Holm A., Andersen A.B., Andersen P. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 1996, 157:3527-3533.
    • (1996) J Immunol , vol.157 , pp. 3527-3533
    • Brandt, L.1    Oettinger, T.2    Holm, A.3    Andersen, A.B.4    Andersen, P.5
  • 35
    • 0034040571 scopus 로고    scopus 로고
    • Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen
    • Olsen A.W., Hansen P.R., Holm A., Andersen P. Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen. Eur J Immunol 2000, 30:1724-1732.
    • (2000) Eur J Immunol , vol.30 , pp. 1724-1732
    • Olsen, A.W.1    Hansen, P.R.2    Holm, A.3    Andersen, P.4
  • 36
    • 11844264031 scopus 로고    scopus 로고
    • Cutting edge: MHC class II-restricted killing in vivo during viral infection
    • Jellison E.R., Kim S.K., Welsh R.M. Cutting edge: MHC class II-restricted killing in vivo during viral infection. J Immunol 2005, 174:614-618.
    • (2005) J Immunol , vol.174 , pp. 614-618
    • Jellison, E.R.1    Kim, S.K.2    Welsh, R.M.3
  • 38
    • 77952356637 scopus 로고    scopus 로고
    • Tuberculosis: what we don't know can, and does, hurt us
    • Russell D.G., Barry C.E., Flynn J.L. Tuberculosis: what we don't know can, and does, hurt us. Science 2010, 328:852-856.
    • (2010) Science , vol.328 , pp. 852-856
    • Russell, D.G.1    Barry, C.E.2    Flynn, J.L.3
  • 40
    • 77958469466 scopus 로고    scopus 로고
    • Immunologic basis of vaccine vectors
    • Liu M.A. Immunologic basis of vaccine vectors. Immunity 2010, 33:504-515.
    • (2010) Immunity , vol.33 , pp. 504-515
    • Liu, M.A.1
  • 41
    • 33847218598 scopus 로고    scopus 로고
    • Vaccine delivery methods using viral vectors
    • Brave A., Ljungberg K., Wahren B., Liu M.A. Vaccine delivery methods using viral vectors. Mol Pharm 2007, 4:18-32.
    • (2007) Mol Pharm , vol.4 , pp. 18-32
    • Brave, A.1    Ljungberg, K.2    Wahren, B.3    Liu, M.A.4
  • 42
  • 43
    • 67349236392 scopus 로고    scopus 로고
    • Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis
    • Mu J., Jeyanathan M., Small C.L., Zhang X., Roediger E., Feng X., et al. Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosis. Mol Ther 2009, 17:1093-1100.
    • (2009) Mol Ther , vol.17 , pp. 1093-1100
    • Mu, J.1    Jeyanathan, M.2    Small, C.L.3    Zhang, X.4    Roediger, E.5    Feng, X.6
  • 45
    • 47049104406 scopus 로고    scopus 로고
    • Kinetics of recombinant adenovirus type 5, vaccinia virus, modified vaccinia Ankara virus, and DNA antigen expression in vivo and the induction of memory T-lymphocyte responses
    • Geiben-Lynn R., Greenland J.R., Frimpong-Boateng K., Letvin N.L. Kinetics of recombinant adenovirus type 5, vaccinia virus, modified vaccinia Ankara virus, and DNA antigen expression in vivo and the induction of memory T-lymphocyte responses. Clin Vaccine Immunol 2008, 15:691-696.
    • (2008) Clin Vaccine Immunol , vol.15 , pp. 691-696
    • Geiben-Lynn, R.1    Greenland, J.R.2    Frimpong-Boateng, K.3    Letvin, N.L.4
  • 46
    • 0036595397 scopus 로고    scopus 로고
    • Cytotoxic Tlymphocytes: all roads lead to death
    • Barry M., Bleackley R.C. Cytotoxic Tlymphocytes: all roads lead to death. Nat Rev Immunol 2002, 2:401-409.
    • (2002) Nat Rev Immunol , vol.2 , pp. 401-409
    • Barry, M.1    Bleackley, R.C.2
  • 47
    • 76749108513 scopus 로고    scopus 로고
    • Model with two types of CTL regulation and experiments on CTL dynamics
    • Sergeev R.A., Batorsky R.E., Rouzine I.M. Model with two types of CTL regulation and experiments on CTL dynamics. J Theor Biol 2010, 263:369-384.
    • (2010) J Theor Biol , vol.263 , pp. 369-384
    • Sergeev, R.A.1    Batorsky, R.E.2    Rouzine, I.M.3
  • 48
    • 34247849183 scopus 로고    scopus 로고
    • Effector and memory CTL differentiation
    • Williams M.A., Bevan M.J. Effector and memory CTL differentiation. Annu Rev Immunol 2007, 25:171-192.
    • (2007) Annu Rev Immunol , vol.25 , pp. 171-192
    • Williams, M.A.1    Bevan, M.J.2
  • 49
    • 0035925587 scopus 로고    scopus 로고
    • Tuberculosis subunit vaccine development: on the role of interferon-gamma
    • Agger E.M., Andersen P. Tuberculosis subunit vaccine development: on the role of interferon-gamma. Vaccine 2001, 19:2298-2302.
    • (2001) Vaccine , vol.19 , pp. 2298-2302
    • Agger, E.M.1    Andersen, P.2
  • 50
    • 34547624348 scopus 로고    scopus 로고
    • Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis
    • Mittrucker H.W., Steinhoff U., Kohler A., Krause M., Lazar D., Mex P., et al. Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis. Proc Natl Acad Sci U S A 2007, 104:12434-12439.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 12434-12439
    • Mittrucker, H.W.1    Steinhoff, U.2    Kohler, A.3    Krause, M.4    Lazar, D.5    Mex, P.6
  • 51
    • 35348925964 scopus 로고    scopus 로고
    • Half-truths and selective memory: interferon gamma, CD4(+) T cells and protective memory against tuberculosis
    • Goldsack L., Kirman J.R. Half-truths and selective memory: interferon gamma, CD4(+) T cells and protective memory against tuberculosis. Tuberculosis (Edinb) 2007, 87:465-473.
    • (2007) Tuberculosis (Edinb) , vol.87 , pp. 465-473
    • Goldsack, L.1    Kirman, J.R.2
  • 52
    • 0344406062 scopus 로고    scopus 로고
    • A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis
    • Skinner M.A., Ramsay A.J., Buchan G.S., Keen D.L., Ranasinghe C., Slobbe L., et al. A DNA prime-live vaccine boost strategy in mice can augment IFN-gamma responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis. Immunology 2003, 108:548-555.
    • (2003) Immunology , vol.108 , pp. 548-555
    • Skinner, M.A.1    Ramsay, A.J.2    Buchan, G.S.3    Keen, D.L.4    Ranasinghe, C.5    Slobbe, L.6
  • 53
    • 67649216110 scopus 로고    scopus 로고
    • Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells
    • Lindenstrom T., Agger E.M., Korsholm K.S., Darrah P.A., Aagaard C., Seder R.A., et al. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 2009, 182:8047-8055.
    • (2009) J Immunol , vol.182 , pp. 8047-8055
    • Lindenstrom, T.1    Agger, E.M.2    Korsholm, K.S.3    Darrah, P.A.4    Aagaard, C.5    Seder, R.A.6
  • 54
    • 36248967655 scopus 로고    scopus 로고
    • Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+memory T lymphocyte populations
    • Beveridge N.E., Price D.A., Casazza J.P., Pathan A.A., Sander C.R., Asher T.E., et al. Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+memory T lymphocyte populations. Eur J Immunol 2007, 37:3089-3100.
    • (2007) Eur J Immunol , vol.37 , pp. 3089-3100
    • Beveridge, N.E.1    Price, D.A.2    Casazza, J.P.3    Pathan, A.A.4    Sander, C.R.5    Asher, T.E.6
  • 55
    • 34250303350 scopus 로고    scopus 로고
    • Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major
    • Darrah P.A., Patel D.T., De Luca P.M., Lindsay R.W., Davey D.F., Flynn B.J., et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007, 13:843-850.
    • (2007) Nat Med , vol.13 , pp. 843-850
    • Darrah, P.A.1    Patel, D.T.2    De Luca, P.M.3    Lindsay, R.W.4    Davey, D.F.5    Flynn, B.J.6
  • 57
    • 29644438544 scopus 로고    scopus 로고
    • The CD8+T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity
    • Yang T.C., Millar J., Groves T., Grinshtein N., Parsons R., Takenaka S., et al. The CD8+T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity. J Immunol 2006, 176:200-210.
    • (2006) J Immunol , vol.176 , pp. 200-210
    • Yang, T.C.1    Millar, J.2    Groves, T.3    Grinshtein, N.4    Parsons, R.5    Takenaka, S.6
  • 58
    • 0036118394 scopus 로고    scopus 로고
    • Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope
    • Harrington L.E., van der Most R., Whitton J.L., Ahmed R. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope. J Virol 2002, 76:3329-3337.
    • (2002) J Virol , vol.76 , pp. 3329-3337
    • Harrington, L.E.1    van der Most, R.2    Whitton, J.L.3    Ahmed, R.4
  • 59
    • 73449147009 scopus 로고    scopus 로고
    • Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+T-cell responses
    • Reyes-Sandoval A., Berthoud T., Alder N., Siani L., Gilbert S.C., Nicosia A., et al. Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+T-cell responses. Infect Immun 2010, 78:145-153.
    • (2010) Infect Immun , vol.78 , pp. 145-153
    • Reyes-Sandoval, A.1    Berthoud, T.2    Alder, N.3    Siani, L.4    Gilbert, S.C.5    Nicosia, A.6
  • 60
    • 34548770610 scopus 로고    scopus 로고
    • Multiple immunizations with adenovirus and MVA vectors improve CD8+T cell functionality and mucosal homing
    • Tatsis N., Lin S.W., Harris-McCoy K., Garber D.A., Feinberg M.B., Ertl H.C. Multiple immunizations with adenovirus and MVA vectors improve CD8+T cell functionality and mucosal homing. Virology 2007, 367:156-167.
    • (2007) Virology , vol.367 , pp. 156-167
    • Tatsis, N.1    Lin, S.W.2    Harris-McCoy, K.3    Garber, D.A.4    Feinberg, M.B.5    Ertl, H.C.6
  • 61
    • 13444274693 scopus 로고    scopus 로고
    • Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection
    • Palendira U., Spratt J.M., Britton W.J., Triccas J.A. Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection. Vaccine 2005, 23:1680-1685.
    • (2005) Vaccine , vol.23 , pp. 1680-1685
    • Palendira, U.1    Spratt, J.M.2    Britton, W.J.3    Triccas, J.A.4
  • 62
    • 64049102311 scopus 로고    scopus 로고
    • CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses
    • Mathurin K.S., Martens G.W., Kornfeld H., Welsh R.M. CD4 T-cell-mediated heterologous immunity between mycobacteria and poxviruses. J Virol 2009, 83:3528-3539.
    • (2009) J Virol , vol.83 , pp. 3528-3539
    • Mathurin, K.S.1    Martens, G.W.2    Kornfeld, H.3    Welsh, R.M.4
  • 63
    • 79959486818 scopus 로고    scopus 로고
    • Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants
    • Ota M.O., Odutola A.A., Owiafe P.K., Donkor S., Owolabi O.A., Brittain N.J., et al. Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants. Sci Transl Med 2011, 3:88ra56.
    • (2011) Sci Transl Med , vol.3
    • Ota, M.O.1    Odutola, A.A.2    Owiafe, P.K.3    Donkor, S.4    Owolabi, O.A.5    Brittain, N.J.6
  • 64
    • 34249944837 scopus 로고    scopus 로고
    • Identification of a human CD8+regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4
    • Joosten S.A., van Meijgaarden K.E., Savage N.D., de Boer T., Triebel F., van der Wal A., et al. Identification of a human CD8+regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci U S A 2007, 104:8029-8034.
    • (2007) Proc Natl Acad Sci U S A , vol.104 , pp. 8029-8034
    • Joosten, S.A.1    van Meijgaarden, K.E.2    Savage, N.D.3    de Boer, T.4    Triebel, F.5    van der Wal, A.6
  • 65
    • 16844369607 scopus 로고    scopus 로고
    • Natural regulatory T cells in infectious disease
    • Belkaid Y., Rouse B.T. Natural regulatory T cells in infectious disease. Nat Immunol 2005, 6:353-360.
    • (2005) Nat Immunol , vol.6 , pp. 353-360
    • Belkaid, Y.1    Rouse, B.T.2
  • 66
    • 33846909485 scopus 로고    scopus 로고
    • Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization
    • Santosuosso M., McCormick S., Roediger E., Zhang X., Zganiacz A., Lichty B.D., et al. Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization. J Immunol 2007, 178:2387-2395.
    • (2007) J Immunol , vol.178 , pp. 2387-2395
    • Santosuosso, M.1    McCormick, S.2    Roediger, E.3    Zhang, X.4    Zganiacz, A.5    Lichty, B.D.6
  • 67
    • 0042346025 scopus 로고    scopus 로고
    • Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara
    • Goonetilleke N.P., McShane H., Hannan C.M., Anderson R.J., Brookes R.H., Hill A.V. Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J Immunol 2003, 171:1602-1609.
    • (2003) J Immunol , vol.171 , pp. 1602-1609
    • Goonetilleke, N.P.1    McShane, H.2    Hannan, C.M.3    Anderson, R.J.4    Brookes, R.H.5    Hill, A.V.6
  • 68
    • 0028973209 scopus 로고
    • Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route
    • North R.J. Mycobacterium tuberculosis is strikingly more virulent for mice when given via the respiratory than via the intravenous route. J Infect Dis 1995, 172:1550-1553.
    • (1995) J Infect Dis , vol.172 , pp. 1550-1553
    • North, R.J.1
  • 69
    • 77954623962 scopus 로고    scopus 로고
    • Airway luminal T cells: a newcomer on the stage of TB vaccination strategies
    • Jeyanathan M., Heriazon A., Xing Z. Airway luminal T cells: a newcomer on the stage of TB vaccination strategies. Trends Immunol 2010, 31:247-252.
    • (2010) Trends Immunol , vol.31 , pp. 247-252
    • Jeyanathan, M.1    Heriazon, A.2    Xing, Z.3
  • 71
    • 44349133474 scopus 로고    scopus 로고
    • Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine
    • Roediger E.K., Kugathasan K., Zhang X., Lichty B.D., Xing Z. Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored tuberculosis vaccine. Mol Ther 2008, 16:1161-1169.
    • (2008) Mol Ther , vol.16 , pp. 1161-1169
    • Roediger, E.K.1    Kugathasan, K.2    Zhang, X.3    Lichty, B.D.4    Xing, Z.5
  • 72
    • 78649714536 scopus 로고    scopus 로고
    • Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
    • Capone S., Reyes-Sandoval A., Naddeo M., Siani L., Ammendola V., Rollier C.S., et al. Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates. Vaccine 2010, 29:256-265.
    • (2010) Vaccine , vol.29 , pp. 256-265
    • Capone, S.1    Reyes-Sandoval, A.2    Naddeo, M.3    Siani, L.4    Ammendola, V.5    Rollier, C.S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.